Nolet Chris

Nolet Chris is listed in filings as Director at ArriVent BioPharma, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including 5 public disclosures. Recent filings connect the profile to ArriVent BioPharma, Inc. (AVBP), Revance Therapeutics, Inc. - Common Stock (RVNC), and Jasper Therapeutics, Inc. (JSPR). The current snapshot covers public activity from Feb 6, 2025 to Jun 22, 2026. Reported amounts are shown as $430.5K to $50.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.